Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor

Journal of Biomedical Optics

Volumn 19, Issue 5, 2014, Pages

  Kim, Chang Beom ^a   Choi, Yu Yong ^b   Song, Woo Keun ^b   Song, Ki Bong ^a  

^a Electronics and Telecommunications Research Institute (ETRI)   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Alzheimer's disease; beta amyloid; magnetoimmunoassay; nanoparticle; salivary A

Indexed keywords

ALZHEIMER'S DISEASE; BETA AMYLOIDS; DIAGNOSTIC POTENTIAL; MAGNETIC NANO-PARTICLES; MAGNETOIMMUNOASSAY; MILD COGNITIVE IMPAIRMENTS; NEURODEGENERATIVE DISORDERS; PHOTO MULTIPLIER TUBE;

ANTIBODIES; BIOMARKERS; BODY FLUIDS; DETECTORS; FLUORESCENCE; GLYCOPROTEINS; NANOPARTICLES; PEPTIDES;

NEURODEGENERATIVE DISEASES;

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; MAGNETITE NANOPARTICLE;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOASSAY; METABOLISM; METHODOLOGY; PHOTON; SALIVA;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HUMANS; IMMUNOASSAY; MAGNETITE NANOPARTICLES; MICROSCOPY, FLUORESCENCE; PHOTONS; SALIVA;

EID: 84889789083     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.5.051205     Document Type: Article

References (39)

1. R. L. Nussbaum et al., "Alzheimer's disease and Parkinson's disease," N. Engl. J. Med. 348(14), 1356-1364 (2003). (Pubitemid 36384104)
2. G. McKhann et al., "Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease," Neurology 34(7), 939-944 (1984). (Pubitemid 14076461)
3. D. H. Small et al., "Alzheimer's disease and A toxicity: from top to bottom," Nat. Rev. Neurosci. 2(8), 595-598 (2001). (Pubitemid 33679833)
4. L. Bertram et al., "The current status of Alzheimer's disease genetics: what do we tell the patients," Pharmacol. Res. 50(4), 385-396 (2004). (Pubitemid 39078530)
5. R. E. Tanzi et al., "Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective," Cell 120(4), 545-555 (2005). (Pubitemid 40269768)
6. L. Bertram et al., "Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses," Nat. Rev. Neurosci. 9(10), 768-778 (2008).
7. J. Williamson et al., "Genetic aspects of Alzheimer disease," Neurologist 15(2), 80-86 (2009).
8. J. Hardy et al., "The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics," Science 297 (5580), 353-356 (2002). (Pubitemid 34790756)
9. S. D. Yan et al., "An intracellular protein that binds amyloid- peptide and mediates neurotoxicity in Alzheimer's disease," Nature 389(6652), 689-695 (1997). (Pubitemid 27458947)
10. D. A. Butterfield et al., "Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid -peptide," Trends Mol. Med. 7 (12), 548-554 (2001). (Pubitemid 33127140)
11. M. Meyer-Luehmann et al., "Extracellular amyloid formation and associated pathology in neural grafts," Nat. Neurosci. 6(4), 370-377 (2003). (Pubitemid 36373982)
12. F. M. LaFerla et al., "Intracellular amyloid- in Alzheimer's disease," Nat. Rev. Neurosci. 8(7), 499-509 (2007).
13. J. F. Reilly et al., "Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model," Proc. Natl. Acad. Sci. U. S. A. 100(8), 4837-4842 (2003). (Pubitemid 36457815)
14. S. L. Pimlott et al., "SPECT imaging in dementia," Br. J. Radiol. 80(2), S153-S159 (2007). (Pubitemid 351799342)
15. W. E. Klunk et al., "Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B," Ann. Neurol. 55(3), 306-319 (2004). (Pubitemid 38269583)
16. K. Shoghi-Jadid et al., "Localization of neurofibrillary tangles and betaamyloid plaques in the brains of living patients with Alzheimer disease," Am. J. Geriatr. Psychiatr. 10(1), 24-35 (2002). (Pubitemid 34052900)
17. M. Hintersteiner et al., "In vivo detection of amyloid- deposits by nearinfrared imaging using an oxazine-derivative probe," Nat. Biotechnol. 23(5), 577-583 (2005). (Pubitemid 41724896)
18. H. Benveniste et al., "Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy," Proc. Natl. Acad. Sci. U. S. A. 96(24), 14079-14084 (1999).
19. M. Higuchi et al., "19F and 1H MRI detection of amyloid plaques in vivo," Nat. Neurosci. 8(4), 527-533 (2005).
20. Z.-H. Cho et al., "A fusion PET-MRI system with a high-resolution research tomograph-PET and ultra-high field 7.0 T-MRI for the molecular-genetic imaging of the brain," Proteomics 8(6), 1302-1323 (2008). (Pubitemid 351462935)
21. K. Blennow, "CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment," Expert Rev. Mol. Diagn. 5(5), 661-672 (2005). (Pubitemid 41337462)
22. K. Blennow et al., "Cerebrospinal fluid and plasma biomarkers in Alzheimer disease," Nat. Rev. Neurol. 6(3), 131-144 (2010).
23. C. Humpel, "Identifying and validating biomarkers for Alzheimer's disease," Trends Biotechnol. 29(1), 26-32 (2011).
24. T. Pfaffe et al., "Diagnostic potential of saliva: current state and future applications," Clin. Chem. 57(5), 675-687 (2011).
25. M. Shi et al., "Salivary tau species are potential biomarkers of Alzheimer's disease," J. Alzheimers Dis. 27(2), 299-305 (2011).
26. J. A. Ship et al., "Diminished submandibular salivary flow in dementia of the Alzheimer type," J. Gerontol. 45(2), M61-M66 (1990). (Pubitemid 20104846)
27. J. A. Ship et al., "Longitudinal study on oral health in subjects with Alzheimer's disease," J. Am. Geriatr. Soc. 42(1), 57-63 (1994). (Pubitemid 24020563)
28. Y. S. Oh et al., "Effect of -secretase inhibitors on muscarinic receptormediated calcium signaling in human salivary epithelial cells," Am. J. Physiol. Cell. Physiol. 291(1), C76-C82 (2006).
29. Z.Wang et al., "Microcontact printing of polyelectrolytes on PEG using an unmodified PDMS stamp for micropatterning nanoparticles, DNA, proteins and cells," Soft Matter 8(29), 7630-7637 (2012).
30. F. Bermejo-Pareja et al., "Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study," BMC Neurol. 10, 108 (2010).
31. M. F. Folstein et al., "Mini-mental state: a practical method for grading the cognitive state of patients for the clinician," J. Psychiatr. Res. 12(3), 189-198 (1975).
32. J. L. Cummings, "Mini-mental state examination norms, normals, and numbers," JAMA 269(18), 2420-2421 (1993). (Pubitemid 23129386)
33. S. A. Decker, "Low salivary cortisol and elevated depressive affect among rural men in Botswana: reliability and validity of laboratory results," J. Physiol. Anthropol. 25(1), 91-101 (2006).
34. K. E. Mostov, "Transepithelial transport of immunoglobulins," Annu. Rev. Immunol. 12, 63-84 (1994). (Pubitemid 24140409)
35. R. Motter et al., "Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease," Ann. Neurol. 38(4), 643-648 (1995).
36. T. Sunderland et al., "Decreased beta-amyloid 1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease," JAMA 289(16), 2094-2103 (2003).
37. M. O. Dietrich et al., "Megalin mediates the transport of leptin across the blood-CSF barrier," Neurobiol. Aging 29(6), 902-912 (2008). (Pubitemid 351601900)
38. A. Tamaoka et al., "Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease," J. Neurol. Sci. 148(1), 41-45 (1997). (Pubitemid 27149523)
39. C. H. Schenck et al., "A case of REM sleep behavior disorder with autopsy-confirmed Alzheimer's disease: postmortem brain stem histochemical analyses," Biol. Psychiatr. 40(5), 422-425 (1996). (Pubitemid 26301076)